Why perimenopause feels so unpredictable

Most women expect perimenopause to arrive like a slow dimmer switch — hormones easing down, body adjusting quietly over time. What many encounter instead is something far less orderly: vivid night sweats for a fortnight, then a week of feeling completely normal, then a sudden wave of anxiety that arrives without obvious cause. The chaos is not imagined. It is biochemical.

At the root of it is the ovary's dwindling follicle reserve. As follicle numbers fall, a signalling hormone called inhibin B drops away, releasing the pituitary from its usual restraint. The pituitary responds by pumping out more and more follicle-stimulating hormone (FSH) in an attempt to coax a response. The result is erratic: oestradiol levels spike abnormally high before crashing low, sometimes within the same cycle. Progesterone, meanwhile, falls more steadily — because sporadic ovulation means the corpus luteum (the structure that produces progesterone after an egg is released) forms far less reliably. Testosterone, too, fluctuates unpredictably across this window.

This is what Professor Paul Lee's Regeneration by Design framework describes as a failure of the body's internal chemical timing system — and it is why the term 'chemistry storm' fits better than 'hormonal decline'. It is the instability itself, not simply lower levels, that drives such wide variation in how women experience this phase. Duration averages three to four years, though it may span only a few months or stretch close to a decade, typically beginning in the mid-40s. The storm does not follow a timetable.

How the storm reaches your brain

The brain feels the storm before many women realise it has started. Progesterone does more than regulate the reproductive cycle: it converts in the brain to a compound called allopregnanolone, which binds to GABA receptors — the nervous system's primary braking mechanism. When progesterone falls away as ovulation becomes sporadic, allopregnanolone falls with it. The brain's natural calming signal weakens. Anxiety surfaces without an obvious trigger. Sleep becomes light and fractured. Irritability arrives disproportionate to events.

Erratic oestrogen adds a second layer of disruption. Oestrogen modulates the production and sensitivity of serotonin and dopamine — the neurotransmitters governing mood, motivation, and working memory. When oestrogen swings unpredictably rather than declining smoothly, so does the chemistry underpinning concentration, emotional regulation, and the ability to retrieve words mid-sentence.

This is not a vague hormonal mood. It is a specific, traceable neurochemical cascade originating in the ovary and arriving in the prefrontal cortex. A 2025 narrative review by Minihane et al., published in PMC, quantified the scale: over 80% of women experience menopausal symptoms, with an estimated 10% leaving the UK workforce as a direct result — figures that speak not just to biology, but to the very real cost of leaving this chemistry unaddressed.

Inflammation and the gut's role in oestrogen recycling

Falling oestrogen does not simply disrupt hormonal signalling — it reshapes two downstream systems in ways that compound the storm's effects.

The first is inflammation. Oestrogen has anti-inflammatory properties, and as levels become erratic and eventually decline, systemic low-grade inflammation rises. This is not acute inflammation; it is a steady background elevation that contributes to the joint stiffness and pain many women notice during perimenopause, worsens brain fog, and shifts cardiovascular risk in an unfavourable direction.

The second mechanism is subtler. A community of gut bacteria — collectively termed the estrobolome — produces an enzyme called β-glucuronidase. The liver normally tags used oestrogen for excretion; β-glucuronidase detaches that tag in the gut, allowing active oestrogen to re-enter the bloodstream. This is a genuine feedback loop within the endocrine system, not merely a digestive side-effect.

When oestrogen falls during perimenopause, gut microbial diversity declines too — impairing exactly the recycling the body most needs and potentially amplifying both symptom severity and bone-density loss beyond what the ovarian numbers alone would predict. Supporting microbial diversity through fibre, fermented foods, and varied whole-food eating may help preserve this loop.

Omega-3s and the critical intervention window

Timing matters in nutrition, and the Minihane et al. review — already cited for its workforce data — makes a second, equally significant argument: the menopausal transition represents a critical window of opportunity for omega-3 intervention. Accumulating RCT data links higher EPA and DHA intake to improvements in vasomotor symptoms, sleep quality, cognitive deficits, mood, and anxiety during the transition itself, though the authors are clear that precise dose–response data are still needed before firm prescriptions can be made.

The two long-chain fatty acids work differently. EPA appears to act along mood and neurotransmitter pathways, which may support the anxiety and low mood that accompany the neurochemical shifts described earlier. DHA is structurally concentrated in the brain — it is a primary building block of neuronal cell membranes — and research suggests it supports memory and counters the kind of midlife brain fog that erratic oestrogen helps create. Their anti-inflammatory properties may also help address the low-grade systemic inflammation covered in the previous section.

For women relying on plant sources — flaxseeds, chia, walnuts — there is a practical limitation worth knowing: ALA, the plant-form precursor, converts to EPA and DHA inefficiently even under normal conditions. During perimenopause, that conversion appears to become less efficient still. Seeds and walnuts remain valuable for general health, but they cannot reliably cover perimenopausal omega-3 needs on their own. Marine sources such as oily fish, or algae-based supplements for those avoiding fish, provide EPA and DHA directly.

The wider dietary toolkit — phytoestrogens, bone, protein, and what to cut

Beyond omega-3s, several other nutritional levers are worth pulling during perimenopause.

Phytoestrogens — plant compounds structurally similar to 17-β-oestradiol, found in soy, tempeh, flaxseeds, and edamame — bind weakly to oestrogen receptors and are associated with reduced hot flash frequency. The historically low rates of vasomotor symptoms in Japanese women are often cited, though dietary and lifestyle differences between populations make direct extrapolation imprecise. The more informative detail may lie in how soy is consumed: isoflavones in fermented forms such as tempeh and miso appear more readily absorbed, and their conversion to active metabolites depends partly on gut bacterial composition — the same microbiome landscape that perimenopause tends to disrupt.

Bone support becomes urgent as declining oestrogen accelerates bone-density loss. NHS guidance recommends 700–1,200 mg of calcium daily and 10–20 mcg of vitamin D; a 2004 RCT — since cited by 134 subsequent studies — confirmed both nutrients benefit peri- and post-menopausal bone. Vitamin K (broccoli, spinach, cabbage) and magnesium (nuts, seeds, beans) further support the structural matrix.

Protein deserves particular emphasis. Professor Paul Lee's Regeneration by Design recommends 1.2–1.6 g per kg of bodyweight daily — a target that serves two distinct purposes when hormonal support for anabolism is weakening: preserving muscle mass and providing the amino-acid scaffold on which bone minerals are deposited.

Gut and glycaemic support comes from high-fibre, low-glycaemic carbohydrates — which help stabilise blood sugar and mood — alongside prebiotic and fermented foods that maintain microbial diversity.

Moderation, not elimination: caffeine, alcohol, and ultra-processed foods are associated with increased hot flash frequency and disrupted sleep. Small, consistent reductions are generally more effective — and more sustainable — than wholesale dietary overhauls.

Managing your chemistry environment this week

Perimenopause is a chemistry inflection point — the moment when the body's internal environment shifts rapidly enough that proactive nutrition begins to matter more, not less. In Professor Paul Lee's Regeneration by Design framework, Chemistry covers nutrition, hormones, and the internal environment, but it is one of four interdependent pillars, and that interdependence is the practical point here.

Dietary shifts compound when Physics and Biology pull in the same direction. Strength training — the Physics layer — preserves muscle and bone while continuing to support endogenous hormone production. Attention to gut health and sleep — the Biology layer — maintains the microbial diversity on which oestrogen recycling, nutrient absorption, and mood regulation partly depend.

Practical Regeneration translates this into a clear starting hierarchy. Four adjustments have the strongest rationale for this specific window: increase EPA and DHA from marine or algae sources; audit protein intake against the 1.2 g/kg minimum; add at least one fermented food daily to support estrobolome function; and reduce the most consistent personal triggers — typically caffeine, alcohol, or ultra-processed foods — incrementally rather than all at once.

These are general wellness strategies, not clinical interventions. Anyone experiencing significant perimenopausal symptoms, or considering hormone replacement therapy, should consult a qualified healthcare professional — the biochemistry covered here is precisely why that conversation is worth having sooner rather than later.

1. [1] Phytoestrogen – Wikipedia. https://en.wikipedia.org/?curid=912933 https://en.wikipedia.org/?curid=912933